Back to School: How biopharma can reboot drug development. Access exclusive analysis here

1016 Quick Takes
BioCentury & Getty Images

Deals

Oct. 16 Quick Takes: Dren Bio’s $60M series A; plus Roche, Synairgen, Astellas-iota and more  

Oct 17, 2020 | 2:42 AM GMT

Dren Bio raises $60M series A to develop cell-depleting engineered proteins
Dren Bio raised a

Read the full 395 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE